- Home
- BBAR vs PTGX Comparison
BBAR vs PTGX Comparison
Compare BBAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAR
- PTGX
- Stock Information
- Founded
- BBAR 1886
- PTGX 2006
- Country
- BBAR Argentina
- PTGX United States
- Employees
- BBAR N/A
- PTGX N/A
- Industry
- BBAR Commercial Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- BBAR Finance
- PTGX Health Care
- Exchange
- BBAR Nasdaq
- PTGX Nasdaq
- Market Cap
- BBAR 2.7B
- PTGX 2.8B
- IPO Year
- BBAR N/A
- PTGX 2016
- Fundamental
- Price
- BBAR $13.57
- PTGX $47.91
- Analyst Decision
- BBAR
- PTGX Strong Buy
- Analyst Count
- BBAR 0
- PTGX 7
- Target Price
- BBAR N/A
- PTGX $52.83
- AVG Volume (30 Days)
- BBAR 597.6K
- PTGX 450.1K
- Earning Date
- BBAR 11-19-2024
- PTGX 11-08-2024
- Dividend Yield
- BBAR 12.13%
- PTGX N/A
- EPS Growth
- BBAR N/A
- PTGX N/A
- EPS
- BBAR 0.24
- PTGX 2.75
- Revenue
- BBAR $2,631,545,762.00
- PTGX $319,120,000.00
- Revenue This Year
- BBAR N/A
- PTGX $400.33
- Revenue Next Year
- BBAR N/A
- PTGX N/A
- P/E Ratio
- BBAR $22.13
- PTGX $17.54
- Revenue Growth
- BBAR N/A
- PTGX 125.73
- 52 Week Low
- BBAR $3.86
- PTGX $13.76
- 52 Week High
- BBAR $14.45
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- BBAR 66.75
- PTGX 60.40
- Support Level
- BBAR $11.22
- PTGX $45.33
- Resistance Level
- BBAR $14.45
- PTGX $48.89
- Average True Range (ATR)
- BBAR 0.63
- PTGX 1.28
- MACD
- BBAR 0.21
- PTGX 0.11
- Stochastic Oscillator
- BBAR 70.11
- PTGX 77.11
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focused on foreign trade, agricultural business, and digital products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.